RACHEAL PRITCHETT: Open Payments
NPI 1174068076 · JACKSON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$778 in 34 payments from 8 companies in 2025. Trend: 2023 $689 · 2024 $648 · 2025 $778
Food & beverage: $778
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 9 | $230 |
| Otsuka America Pharmaceutical, Inc. | 11 | $158 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $148 |
| Vanda Pharmaceuticals Inc. | 5 | $105 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $56 |
| Janssen Pharmaceuticals, Inc | 2 | $43 |
| Lundbeck LLC | 1 | $19 |
| ABBVIE INC. | 1 | $18 |
Products named: Auvelity, REXULTI, CAPLYTA, FANAPT, TRINTELLIX, SPRAVATO, VRAYLAR, ABILIFY MAINTENA.
Industry payments across MS — which companies pay providers there.
